Storm Therapeutics

Storm Therapeutics, is a spin-out company from the University of Cambridge’s Gurdon Institute focused on the identification and development of small molecule drugs that target RNA-modifying enzymes, opening up novel therapeutic targets in cancer treatment. Storm Therapeutics is based in Cambridge, UK.

Team Member
more about
Hakan Goker
Latest News Entry
Storm Therapeutics expands collaboration with Evotec on Storm's RNA Epigenetics Platform

STORM Therapeutics and Evotec to exploit RNA modulating enzymes for novel epigenetic drug discovery

all portfolio news